XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCENDIA PURCHASE AGREEMENT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cash consideration $ 10,000,000.0          
Number of shares 486,145          
Income tax benefit   $ 1,702,890 $ 4,100,000 $ 5,844,796
Scendia Acquisition [Member]            
Business Combination, Acquisition Related Costs   $ 33,000     $ 187,000  
Purchase Agreement [Member]            
Issuance of common stock for purchase of assets 291,686          
Number of shares issued 94,798          
Proceeds from offering $ 1,950,000          
Purchase Agreement [Member] | Scendia Biologics LLC [Member]            
Merger agreement cash consideration $ 1,300,000          
Scendia Biologics LLC [Member]            
Equity method ownership percentage by parent 50.00%          
Membership Interest Purchase Agreement [Member]            
Equity method ownership percentage 100.00%          
Scendia Biologics LLC [Member]            
Equity method ownership percentage 50.00%          
Scendia Biologics LLC [Member] | Scendia Purchase Agreement [Member]            
Equity method ownership percentage 100.00%